Overview

Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Topaz Pharmaceuticals Inc
Treatments:
Ivermectin